Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C6H12O7 |
Molecular Weight | 196.1553 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O
InChI
InChIKey=RGHNJXZEOKUKBD-SQOUGZDYSA-N
InChI=1S/C6H12O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-5,7-11H,1H2,(H,12,13)/t2-,3-,4+,5-/m1/s1
Molecular Formula | C6H12O7 |
Molecular Weight | 196.1553 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P02792|||Q9BTZ8 Gene ID: 2512.0 Gene Symbol: FTL Target Organism: Homo sapiens (Human) Sources: https://www.drugbank.ca/drugs/DB09517 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Ferrlecit Approved UseFerrlecit is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. Launch Date9.1929602E11 |
|||
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
12.9 μg/mL |
1.5 mg/kg single, intravenous dose: 1.5 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
GLUCONATE ION plasma | Homo sapiens population: UNHEALTHY age: CHILD sex: FEMALE / MALE food status: UNKNOWN |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
95 μg × h/mL |
1.5 mg/kg single, intravenous dose: 1.5 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
GLUCONATE ION plasma | Homo sapiens population: UNHEALTHY age: CHILD sex: FEMALE / MALE food status: UNKNOWN |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
2 h |
1.5 mg/kg single, intravenous dose: 1.5 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
GLUCONATE ION plasma | Homo sapiens population: UNHEALTHY age: CHILD sex: FEMALE / MALE food status: UNKNOWN |
PubMed
Title | Date | PubMed |
---|---|---|
Adverse reactions associated with mobile therapeutic apheresis: analysis of 17,940 procedures. | 2001 |
|
Effects of P5, a novel oxazolo(3,2-a)pyridine derivative with a long-acting antihypertensive activity, on different agonist-mediated pressor responses in pithed rats. | 2001 Apr |
|
Crystallization and preliminary X-ray crystallographic studies of recombinant thermoresistant gluconate kinase GntK from Escherichia coli. | 2001 Aug |
|
Iron sucrose or ferric gluconate? | 2001 Dec |
|
Post-natal ontogeny of stanniocalcin gene expression in rodent kidney and regulation by dietary calcium and phosphate. | 2001 Dec |
|
Biosynthesis of poly(3-hydroxybutyrate-co-3-mercaptobutyrate) as a sulfur analogue to poly(3-hydroxybutyrate) (PHB). | 2001 Fall |
|
Cryptdin-3 induces novel apical conductance(s) in Cl- secretory, including cystic fibrosis, epithelia. | 2001 Feb |
|
Observations on amphotericin B treatment of kala-azar given in a rural set up in Bihar, India. | 2001 Jan |
|
Inhibitors of the Cl-/HCO3- exchanger activate an anion channel with similar features in the epithelial cells of rabbit gallbladder: patch-clamp analysis. | 2001 Jan |
|
Azospirillum doebereinerae sp. nov., a nitrogen-fixing bacterium associated with the C4-grass Miscanthus. | 2001 Jan |
|
Method development and validation for the determination of various sulfur-containing anions and other anions in the corrosion process by capillary ion electrophoresis with indirect detection. | 2001 Jan |
|
Usefulness of the combination of pre- and intraoperative selective intraarterial calcium injection to detect residual insulinomas. | 2001 Jan |
|
Saphenous vein endothelial cell viability: a comparative study of endoscopic and open saphenectomy for coronary artery bypass grafting. | 2001 Jan-Mar |
|
Simplified citrate anticoagulation for continuous renal replacement therapy. | 2001 Jul |
|
Gluconobacter oxydans: its biotechnological applications. | 2001 Jul |
|
Imaging and localization of pancreatic insulinomas. | 2001 Jul-Aug |
|
Organ heavy-metal accumulation during parenteral nutrition is associated with pathologic abnormalities in rats. | 2001 Jul-Aug |
|
Hypocalcaemia and hypomagnesaemia due to hydrofluoric acid. | 2001 Jun |
|
Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. | 2001 Jun |
|
A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo. | 2001 Jun |
|
Ionochromic properties of long-wave-sensitive cones in the goldfish retina: an electrophysiological and microspectrophotometric study. | 2001 Jun |
|
Heterologous expression of the acyl-acyl carrier protein thioesterase gene from the plant Umbellularia californica mediates polyhydroxyalkanoate biosynthesis in recombinant Escherichia coli. | 2001 Mar |
|
Management of extravasation injuries. | 2001 May |
|
Blocking swelling-activated chloride current inhibits mouse liver cell proliferation. | 2001 May 1 |
|
Aluminium toxicity and iron homeostasis. | 2001 Nov |
|
Functional atrioventricular block in a preterm infant. | 2001 Nov |
|
Role of CFTR's PDZ1-binding domain, NBF1 and Cl(-) conductance in inhibition of epithelial Na(+) channels in Xenopus oocytes. | 2001 Nov 1 |
|
Hypocalcemia in the newborn. | 2001 Oct |
|
Chemical mechanism of beta-xylosidase from Trichoderma reesei QM 9414: pH-dependence of kinetic parameters. | 2001 Oct |
|
Considerations for optimal iron use for anemia due to chronic kidney disease. | 2001 Oct |
|
On-line coupling of a miniaturized bioreactor with capillary electrophoresis, via a membrane interface, for monitoring the production of organic acids by microorganisms. | 2001 Sep |
|
Thioglucosidase activity from Sphingobacterium sp. strain OTG1. | 2001 Sep |
|
[Possible treatments of glottic spasm]. | 2001 Sep |
|
Identification and determination of glucuronides and their aglycones in Erigeron breviscapus by liquid chromatography-tandem mass spectrometry. | 2001 Sep 14 |
|
Development of a process for the biotechnological large-scale production of 4-hydroxyvalerate-containing polyesters and characterization of their physical and mechanical properties. | 2001 Spring |
|
Activation of P2X(7) receptors induced [(3)H]GABA release from the RBA-2 type-2 astrocyte cell line through a Cl(-)/HCO(3)(-)-dependent mechanism. | 2002 Jan |
|
The available intravenous iron formulations: History, efficacy, and toxicology. | 2017 Jun |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28391437
8 weeks of IV ferric gluconate 125 mg weekly
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4026827
The effect of iron(III)-gluconate (Ferlixit) at various concentrations
on the malondialdehyde production in isolated rat liver mitochondria
was studied. Concentratiors of iron as low as 100 uM are
able to elicit a significant enhancement of lipid peroxidation.
process.
Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Jul 05 22:50:12 UTC 2023
by
admin
on
Wed Jul 05 22:50:12 UTC 2023
|
Record UNII |
R4R8J0Q44B
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
1108 (Number of products:5)
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
||
|
EPA PESTICIDE CODE |
104
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
||
|
JECFA EVALUATION |
INS-574
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
||
|
NCI_THESAURUS |
C360
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
33198
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY | |||
|
SUB13980MIG
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY | |||
|
DB13180
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY | |||
|
526-95-4
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY | |||
|
487
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY | |||
|
3264
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY | |||
|
R4R8J0Q44B
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY | |||
|
2475956
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY | |||
|
C61777
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY | |||
|
M5762
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY | Merck Index | ||
|
R4R8J0Q44B
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY | |||
|
100000078190
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY | |||
|
77381
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY | |||
|
DTXSID8027169
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY | |||
|
10690
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY | |||
|
GLUCONIC ACID
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY | |||
|
208-401-4
Created by
admin on Wed Jul 05 22:50:12 UTC 2023 , Edited by admin on Wed Jul 05 22:50:12 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |